Covalent “Locking” of Prodrug Nanoassemblies via Thiol‐Ene Click Crosslinking for Potent Antitumor Therapy
Advanced Healthcare Materials · 2026-08 · 15 (31)
DOI: 10.1002/adhm.71453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.07.2026. Verfasst von Xuan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Sulfhydryl Compounds, Nanoparticles. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation, Liaoning Province Natural Science Foundation Program, General Program of Department of Education of Liaoning Province.
Abstract (Originalsprache)
Prodrug nanoassemblies formed by the self‐assembly of prodrugs represent an emerging platform, offering advantages such as high drug loading, facile preparation, and tumor selectivity. However, existing prodrug nanoassemblies primarily depend on noncovalent intermolecular interactions to maintain structural integrity, rendering them vulnerable to in vivo instability and severely constraining their clinical translation. To overcome those limitations, we introduce a mild and efficient thiol‐ene click reaction to construct prodrug nanoassemblies reinforced by a covalently crosslinked network. Specifically, prodrugs are designed by conjugating cabazitaxel (CTX) to tri‐alkene‐containing side chains via tumor redox‐responsive bonds. These prodrugs spontaneously assemble into nanoassemblies enriched with surface‐exposed olefin groups, which are subsequently “locked” by covalent crosslinking using tetra‐arm thiol crosslinkers. The resulting covalently crosslinked prodrug nanoassemblies exhibit markedly improved stability, leading to prolonged systemic circulation and enhanced tumor accumulation, thereby translating into superior antitumor efficacy. Moreover, the redox‐cleavable bond enables tumor microenvironment‐responsive drug release, effectively mitigating the systemic toxicity of CTX while preserving its antitumor potency. Collectively, this covalent “locking” strategy provides a notable advancement in optimizing the structural stability of prodrug nanoassemblies and offers a promising strategy for developing novel chemotherapeutic delivery platforms that integrate circulatory stability with tumor selectivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China.
- Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang, China.
ORCID-Profile: Jin Sun, Bingjun Sun
Förderung
- National Natural Science Foundation
- Liaoning Province Natural Science Foundation Program
- General Program of Department of Education of Liaoning Province
- Postdoctoral Fellowship Program of CPSF
Zitieren
APA
Li, X., Li, L., Zhao, Y., Cui, J., Zhang, L., Sun, J., & Sun, B. (2026). Covalent “Locking” of Prodrug Nanoassemblies via Thiol‐Ene Click Crosslinking for Potent Antitumor Therapy. Advanced Healthcare Materials, 15(31). https://doi.org/10.1002/adhm.71453
Vancouver
Li X, Li L, Zhao Y, Cui J, Zhang L, Sun J, et al. Covalent “Locking” of Prodrug Nanoassemblies via Thiol‐Ene Click Crosslinking for Potent Antitumor Therapy. Advanced Healthcare Materials. 2026;15(31). doi:10.1002/adhm.71453
BibTeX
@article{Li2026,
author = {Li, Xuan and Li, Lingxiao and Zhao, Yingjie and Cui, Jiakun and Zhang, Lurong and Sun, Jin and Sun, Bingjun},
title = {Covalent “Locking” of Prodrug Nanoassemblies via Thiol‐Ene Click Crosslinking for Potent Antitumor Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {31},
doi = {10.1002/adhm.71453}
}
EUVIMED